In the Journals

This feature offers timely executive summaries of the most relevant journals in hepatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

Certain medical devices with FDA priority review have higher recall rates

March 31, 2020
High-risk, or class 3, medical devices that underwent FDA priority review had higher recall rates and less time on the market before serious recalls…
In the Journals

Diet, microbiota changes linked with minimal hepatic encephalopathy in cirrhosis

March 28, 2020
Changes in diet and microbiota were linked with minimal hepatic encephalopathy and hospitalizations in patients with cirrhosis from Mexico compared…
In the Journals

Liver cancer rates rise in developed countries, elderly populations

March 23, 2020
Primary liver cancer rates continue to increase in many regions of the world despite extensive efforts to prevent the disease, according to study…
In the Journals

Aspirin may reduce risk for hepatocellular carcinoma, liver-related mortality in chronic viral hepatitis

March 11, 2020
Low-dose aspirin use appeared associated with significantly lower risk for hepatocellular carcinoma and lower liver-related mortality among patients…
In the Journals

Health-related quality of life linked with mortality, hospitalizations in cirrhosis

March 3, 2020
Health-related quality of life scores may be useful prognostic screening tools for patients with cirrhosis, according to research published in The
In the Journals

Study confirms relevance of SVR endpoint for patients receiving HCV treatment

February 28, 2020
SVR, which has been challenged in regard to its association with clinical outcomes, has been confirmed as a prognosis-altering endpoint in patients…
In the Journals

Kidneys from donors with hepatitis C virus increased recipient life expectancy, reduced costs

February 27, 2020
Transplanting kidneys from donors with hepatitis C virus into uninfected recipients reduced costs to the health care system, while also increasing…
In the Journals

DDIs affect around 40% of HCV patients taking DAAs

February 24, 2020
Drug-drug interactions, or DDIs, affect about 40% of patients with hepatitis C virus being treated with direct-acting antivirals, or DAAs, according…
In the Journals

90% of injection drug users miss opportunities for HIV or HCV testing

February 20, 2020
Using data from more than 840,000 health care encounters, researchers estimated that around 90% of people who inject drugs missed opportunities for…
In the Journals

‘It pays’ to check the gut microbiome in patients with cirrhosis

February 11, 2020
Gut microbiota analysis was cost-effective for predicting and possibly preventing 90-day readmissions for cirrhosis, according to study results. …